This is part two of our interview with Adam Deitz, Founder and CEO of Ortho Kinematics. It is continued from here. How have surgeons responded to the KineGraph VMA technology? Adam Deitz: Surgeons love this technology because it gives them... more
Recently we sat down with Adam Deitz, Founder and CEO of Ortho Kinematics to talk about his company's technology, unmet needs in spine surgery and advancing diagnostic capabilities for surgeons. This interview will be published in two parts. Adam, why... more
Continued from yesterday, below is part two of our interview with Gerald Masoudi , a partner in Covington & Burling LLP's Washington, DC office and co-chair of the Food and Drug practice group. Mr. Masoudi most recently served as Chief... more
Gerald Masoudi is a partner in Covington & Burling LLP's Washington, DC office and co-chair of the Food and Drug practice group. Mr. Masoudi most recently served as Chief Counsel of the Food and Drug Administration. HealthpointCapital: Could you... more
In recent interviews, Medtronic CEO Bill Hawkins discussed some of the challenges associated with the company's $4.2 billion acquisition of Kyphon in 2007 as well as plans for future acquisitions. Kyphon brought innovative products and an entree into new markets,... more
Earlier this week we interviewed Wachovia's industrious medical technology and device analyst Mike Matson to revisit his thoughts on how the credit market dislocations are affecting hospital capital spending decisions. McCormick: Mike, thank you for joining us especially with all... more
Traduction française ci-dessous HC: For our readers who are not familiar with the Argospine association, could you tell us a little about its history and founding concepts? CM: The association started off as a business collaboration between Pr. Pierre Kehr,... more
J. Kevin McGraw, MD, FSIR is the Co-Director of Vascular and Interventional Radiology Riverside Methodist Hospital in Columbus, Ohio and a Clinical Assistant Professor of Radiology at the Medical College of Ohio in Toledo, Ohio. He currently serves on... more
Invibio, principal supplier of PEEK polymer, an increasingly important material used in orthopedic applications, announced earlier this month the launch of a new device material, ENDOLIG(TM) composite, a biocompatible carbon fiber reinforced thermoplastic material. On their website, the company highlights... more
HealthpointCapital's Interview with Jack Fleischer While conducting informational interviews for our latest research report on GPOs, we were fortunate enough to have the opportunity to speak with Jack Fleischer, VP of Strategic Sourcing at New York-Presbyterian Hospital, The University Hospital... more
Last week, we had the good fortune of catching up with Dr. Edward Benzel, Chairman of the Cleveland Clinic Spine Institute. We spent a few minutes with him at this year's Congress of Neurological Surgeons in Boston. At The Cleveland... more
One of the leaders in this emerging meniscus repair market is ReGen Biologics. We recently had a chance to do a catch up with Gary Bisbee, CEO of ReGen Biologics who we interviewed last year. Disclosure: Individual members of HealthpointCapital,... more
Today we are publishing our recent interview with Mike Callahan Managing Director of Invibio, ltd. Many of you know Invibio as a principal supplier of PEEK polymer to the industry an increasingly important material used in orthopedic applications. Q: How... more
In our efforts to poll surgeons on the subject of artificial lumbar discs, we have been tracking down advocates as well as dissenters in order to get a balanced view. Last month at AANS we interviewed Dr. Fred Geisler who... more
Last week I caught up with Dr. Fred Geisler at AANS in New Orleans to discuss artificial disc clinical trials and surgeon adoption of artificial discs. Throughout the week, Dr. Geisler led the Academy as the principal thought leader on... more
Claude LeDuc, CEO Biosyntech Last week we interviewed Claude LeDuc, President and Chief Executive Officer of BioSyntech, a Canadian developer of thermosensitive gels that address articular cartilage repair and other clinical needs. JM: Introduce our readers to BST-Gel™ and... more
Cartilage repair is coming of age. One of the leaders in this emerging technology is ReGen Biologics. During the recent HealthpointCapital Biologics Summit, we spent a few quality moments interviewing Gary Bisbee, CEO of ReGen Biologics. JM: Introduce our Readers... more
Complete Archive
